Manulife (Manufacturers Life Insurance) Portfolio holdings
AUM
$112B
This Quarter Return
-1.72%
1 Year Return
+19.76%
3 Year Return
+56.91%
5 Year Return
+121.6%
10 Year Return
+261.3%
AUM
$172B
AUM Growth
+$172B
(-4.1%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
0.73%
Top 10 Holdings %
Top 10 Hldgs %
34.23%
Holding
3,055
New
97
Increased
1,757
Reduced
732
Closed
80
Top Buys
| 1 |
Visa
V
|
$230M |
| 2 |
Nasdaq
NDAQ
|
$208M |
| 3 |
Crown Castle
CCI
|
$195M |
| 4 |
Union Pacific
UNP
|
$189M |
| 5 |
Moderna
MRNA
|
$175M |
Top Sells
| 1 |
Vanguard Total Bond Market
BND
|
$762M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$476M |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
$217M |
| 4 |
Danaher
DHR
|
$199M |
| 5 |
Canadian National Railway
CNI
|
$191M |
Sector Composition
| 1 | Technology | 10.52% |
| 2 | Financials | 8.5% |
| 3 | Healthcare | 7.07% |
| 4 | Consumer Discretionary | 5.06% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRTS
2901
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $63K | ﹤0.01% |
36,620
| – | – |
|
2902
Origin Materials
ORGN
$82.2M
| $62.6K | ﹤0.01% |
48,905
+4,898
| +11% | +$6.27K |
|
|
MOND
2903
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $62.3K | ﹤0.01% |
17,447
+48
| +0.3% | +$171 |
|
|
VLD
2904
DELISTED
Velo3D, Inc.
VLD
| $61.3K | ﹤0.01% |
39,317
| – | – |
|
2905
BRC Inc
BRCC
$175M
| $61.3K | ﹤0.01% |
17,083
| – | – |
|
2906
BARK
BARK
$147M
| $61.3K | ﹤0.01% |
+51,099
| New | +$61.3K |
|
2907
PDS Biotechnology
PDSB
$60.6M
| $61.3K | ﹤0.01% |
12,134
| – | – |
|
2908
BlackSky Technology
BKSY
$583M
| $61.2K | ﹤0.01% |
52,309
| – | – |
|
|
INZY
2909
DELISTED
Inozyme Pharma
INZY
| $61.1K | ﹤0.01% |
14,552
-138
| -0.9% | -$580 |
|
2910
Relmada Therapeutics
RLMD
$48.8M
| $61K | ﹤0.01% |
20,343
| – | – |
|
2911
Codexis
CDXS
$218M
| $59.4K | ﹤0.01% |
31,425
-262
| -0.8% | -$495 |
|
2912
Century Casinos
CNTY
$83.5M
| $58.3K | ﹤0.01% |
11,363
| – | – |
|
2913
FiscalNote
NOTE
$66.2M
| $58.2K | ﹤0.01% |
27,973
+18
| +0.1% | +$25 |
|
|
PPTA
2914
Perpetua Resources
PPTA
$2.07B
| $56.5K | ﹤0.01% |
17,340
+6,884
| +66% | +$22.4K |
|
2915
X4 Pharmaceuticals
XFOR
$70M
| $56.2K | ﹤0.01% |
51,592
-98
| -0.2% | -$98 |
|
|
WE
2916
DELISTED
WeWork Inc.
WE
| $54.9K | ﹤0.01% |
18,228
+5,348
| +42% | +$53.9K |
|
2917
Altimmune
ALT
$325M
| $53.5K | ﹤0.01% |
20,569
| – | – |
|
2918
Inogen
INGN
$213M
| $53.1K | ﹤0.01% |
10,170
| – | – |
|
2919
Mersana Therapeutics
MRSN
$34.8M
| $52.9K | ﹤0.01% |
41,657
+791
| +2% | +$984 |
|
2920
ClearPoint Neuro
CLPT
$291M
| $51.6K | ﹤0.01% |
10,305
| – | – |
|
2921
Rimini Street
RMNI
$392M
| $50.3K | ﹤0.01% |
22,848
+156
| +0.7% | +$343 |
|
2922
Purple Innovation
PRPL
$118M
| $47.6K | ﹤0.01% |
27,831
-879
| -3% | -$1.5K |
|
2923
Annexon
ANNX
$225M
| $47.3K | ﹤0.01% |
20,021
| – | – |
|
2924
Senti Biosciences
SNTI
$37.9M
| $47.1K | ﹤0.01% |
110,973
-6,898
| -6% | -$2.93K |
|
2925
Stoke Therapeutics
STOK
$1.08B
| $46.9K | ﹤0.01% |
11,916
-35,355
| -75% | -$139K |
|